Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been clinically diagnosed with ulcerative colitis (a type of inflammatory bowel condition), for any length of time
- People between 18 and 65 years of age
- People who have signed a form agreeing to take part in the trial
- People whose colonoscopy or similar examination has shown signs of inflammation in the colon
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant or breastfeeding
- People who have an allergy to milk
- People who have a serious ongoing health condition such as uncontrolled diabetes, unstable heart or lung disease, or cancer
- People who have HIV, CMV (cytomegalovirus), Hepatitis B or C, or whose liver enzyme levels (AST or ALT) were found to be more than three times higher than normal at the screening test
- People who have taken part in another clinical drug trial within the 30 days before joining this study
- People whose colon has a hole or tear (known as a perforation)
- People experiencing severe, life-threatening bleeding from the colon that requires emergency surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lior Kats, MD, Hadassah Medical Organization
Phone: 972-546765638
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Clinical Benefit #1; Clinical Benefits #2; Safety and Tolerability of WPMDE2 #1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.